SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 18 filers reported holding SEATTLE GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,561,000 | +108.4% | 7,976 | +22.8% | 0.01% | -12.5% |
| Q2 2020 | $749,000 | 0.0% | 6,495 | 0.0% | 0.02% | +100.0% |
| Q1 2020 | $749,000 | +13.8% | 6,495 | +12.7% | 0.01% | +60.0% |
| Q4 2019 | $658,000 | +44.6% | 5,762 | +8.0% | 0.01% | +25.0% |
| Q3 2019 | $455,000 | +33.8% | 5,333 | +8.5% | 0.00% | +33.3% |
| Q2 2019 | $340,000 | -5.8% | 4,915 | -0.2% | 0.00% | 0.0% |
| Q1 2019 | $361,000 | +29.4% | 4,925 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $279,000 | -22.9% | 4,925 | +4.9% | 0.00% | 0.0% |
| Q3 2018 | $362,000 | +24.0% | 4,695 | +6.8% | 0.00% | +50.0% |
| Q2 2018 | $292,000 | +27.0% | 4,395 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $230,000 | +32.2% | 4,395 | +35.2% | 0.00% | +100.0% |
| Q4 2017 | $174,000 | +20.8% | 3,250 | +22.6% | 0.00% | 0.0% |
| Q3 2017 | $144,000 | +5.1% | 2,650 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $137,000 | -18.0% | 2,650 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $167,000 | +695.2% | 2,650 | +562.5% | 0.00% | – |
| Q4 2016 | $21,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |